BeStock  
Stocks › Biotechnology › ANAB

AnaptysBio ANAB

US equityMarket cap rank #2932Biotechnology
$46.63 −$0.77 (-1.62%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $46.63 0.00%
Open$47.49
Prev close$47.40
Day range$46.05 – $47.71
Volume432.5K
Market cap$1.39B
P/E (TTM)9.0
Dividend yield–

ANAB Stock News

Headlines matching AnaptysBio or the ANAB ticker, most recent first.

  • J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating, Cuts Target Price to $60 NegativeMarket news · 30 Sep 2026 · Direct mention
  • Barclays Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $75Market news · 23 Sep 2026 · Direct mention
  • Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy Rating, Announces Target Price $81Market news · 23 Sep 2026 · Direct mention
  • UBS Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $76Market news · 22 Sep 2026 · Direct mention
  • TD Cowen Maintains AnaptysBio(ANAB.US) With Buy RatingMarket news · 25 Aug 2026 · Direct mention
  • TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating, Cuts Target Price to $70 NegativeMarket news · 25 Aug 2026 · Direct mention
  • Piper Sandler Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $93Market news · 22 Jul 2026 · Direct mention
  • TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $75Market news · 13 Jul 2026 · Direct mention
  • H.C. Wainwright Initiates AnaptysBio(ANAB.US) With Buy Rating, Announces Target Price $95Market news · 10 Jun 2026 · Direct mention
  • Piper Sandler Maintains AnaptysBio(ANAB.US) With Buy Rating, Cuts Target Price to $93 NegativeMarket news · 4 May 2026 · Direct mention
  • Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy RatingMarket news · 27 May 2026 · Direct mention
  • J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating, Raises Target Price to $70 PositiveMarket news · 23 May 2026 · Direct mention
  • Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy Rating, Raises Target Price to $90 PositiveMarket news · 15 May 2026 · Direct mention
  • A Quick Look at Today's Ratings for AnaptysBio(ANAB.US), With a Forecast Between $75 to $93Market news · 13 May 2026 · Direct mention
  • UBS Maintains AnaptysBio(ANAB.US) With Buy Rating, Raises Target Price to $76 PositiveMarket news · 13 May 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ANAB.

Sign in to join the discussion.

Scroll to Top